Related Experiment Video
Updated: Jun 20, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Prevention of bronchopulmonary dysplasia
Matthew M Laughon1, P Brian Smith, Carl Bose
1UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. matt_laughon@med.unc.edu
Abstract:
Considerable effort has been devoted to the development of strategies to reduce the incidence of bronchopulmonary dysplasia (BPD), including use of medications, nutritional therapies, and respiratory care practices. Unfortunately, most of these strategies have not been successful. To date, the only two treatments developed specifically to prevent BPD whose efficacy is supported by evidence from randomized, controlled trials are the parenteral administration of vitamin A and corticosteroids. Two other therapies, the use of caffeine for the treatment of apnea of prematurity and aggressive phototherapy for the treatment of hyperbilirubinemia, were evaluated for the improvement of other outcomes and found to reduce BPD. Cohort studies suggest that the use of continuous positive airway pressure as a strategy for avoiding mechanical ventilation might also be beneficial. Other therapies reduce lung injury in animal models but do not appear to reduce BPD in humans. The benefits of the efficacious therapies have been modest, with an absolute risk reduction in the 7-11% range. Further preventive strategies are needed to reduce the burden of this disease. However, each will need to be tested in randomized, controlled trials, and the expectations of new therapies should be modest reductions of the incidence of the disease.
Insights
Preventing bronchopulmonary dysplasia (BPD) in premature infants remains challenging. While vitamin A, corticosteroids, caffeine, and phototherapy show modest benefits, new strategies with proven efficacy are needed.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Critical Care
Background:
- Bronchopulmonary dysplasia (BPD) is a significant complication in premature infants.
- Despite extensive research, most strategies to prevent BPD have proven unsuccessful.
Purpose of the Study:
- To review the evidence for therapies aimed at reducing the incidence of BPD.
- To identify effective BPD prevention strategies and highlight the need for further research.
Main Methods:
- Review of randomized controlled trials (RCTs) and cohort studies.
- Analysis of existing literature on BPD prevention therapies.
Main Results:
- Parenteral vitamin A and corticosteroids are the only BPD-specific preventive treatments with RCT-supported efficacy.
- Caffeine for apnea of prematurity and aggressive phototherapy for hyperbilirubinemia also reduce BPD incidence.
- Continuous positive airway pressure (CPAP) may reduce BPD by avoiding mechanical ventilation, supported by cohort studies.
- Many other therapies show promise in animal models but lack human efficacy for BPD prevention.
- Efficacious therapies provide modest benefits, with absolute risk reductions of 7-11%.
Conclusions:
- Current effective BPD prevention strategies offer limited benefits.
- Further research and rigorous testing in RCTs are essential for developing new, effective BPD preventive strategies.
- Modest reductions in BPD incidence should be the expectation for novel therapies.
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Respiratory Syncytial Virus Disease
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Breathing